Immunogenicity of newly constructed attenuated vaccinia strain LC16m8Δ that expresses SIV Gag protein

Vaccine

Volumn 27, Issue 7, 2009, Pages 966-971

  Suzuki, Hajime ^a   Kidokoro, Minoru ^b   Fofana, Ismael Ben ^a   Ohashi, Takashi ^a   Okamura, Tomotaka ^b   Matsuo, Kazuhiro ^b   Yamamoto, Naoki ^b   Shida, Hisatoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

IFN producing T cells; SIV gag; Vaccinia m8

Indexed keywords

DNA; GAG PROTEIN; GAMMA INTERFERON; POL PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MACACA; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION;

AIDS VACCINES; ANIMALS; FEMALE; GENE PRODUCTS, GAG; HUMANS; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VACCINES, DNA; VACCINIA;

EID: 58549098064     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.015     Document Type: Article

References (31)

1. Casimiro D.R., Wang F., Schleif W.A., Liang X., Zhang Z., Tobery T.W., et al. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J Virol 79 24 (2005) 15547-15555
2. Cox K.S., Clair J.H., Prokop M.T., Sykes K.J., Dubey S.A., Shiver J.W., et al. DNAgag/Ad5gag and Ad5gag/Ad5gag vaccines induce distinct T cell response profiles. J Virol 82 16 (2008) 8161-8171
3. Vogel T.U., Reynolds M.R., Fuller D.H., Vielhuber K., Shipley T., Fuller J.T., et al. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol 77 24 (2003) 13348-13360
4. Goonetilleke N., Moore S., Dally L., Winstone N., Cebere I., Mahmoud A., et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8 T-cell epitopes. J Virol 80 10 (2006) 4717-4728
5. Harari A., Bart P.A., Stöhr W., Tapia G., Garcia M., Medjitna-Rais E., et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med 205 1 (2008) 63-77
6. Walker B.D., and Burton D.R. Toward and AIDS Vaccine. Science 320 5877 (2008) 760-764
7. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 6869 (2002) 331-335
8. Hashizume S., Yoshizawa H., Morita M., and Suzuki K. Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain. In: Ouinnan G.V. (Ed). In Vaccinia viruses as Vectors for Vaccine Antigens (1985), Elsevier, Amsterdam 421-428
9. Kidokoro M., Tashiro M., and Shida H. Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8. Proc Natl Acad Sci USA 102 11 (2005) 4152-4157
10. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13 1 (2007) 46-53
11. Matano T., Kobayashi M., Igarashi H., Takeda A., Nakamura H., Kano M., et al. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J Exp Med 199 12 (2004) 1709-1718
12. Okamura T., Someya K., Matsuo K., Hasegawa A., Yamamoto N., and Honda M. Recombinant vaccinia DIs expressing simian immunodeficiency virus gag and pol in mammalian cells induces efficient cellular immunity as a safe immunodeficiency virus vaccine candidate. Microbiol Immunol 50 12 (2006) 989-1000
13. Amano H., Morikawa S., Shimizu H., Shoji I., Kurosawa D., Matsuura Y., et al. Identification of the canarypox virus thymidine kinase gene and insertion of foreign genes. Virology 256 2 (1999) 280-290
14. Ishii K., Ueda Y., Matsuo K., Matsuura Y., Kitamura T., Kato K., et al. Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector. Virology 302 2 (2002) 433-444
15. Kestler H., Kodama T., Ringler D., Marthas M., Pedersen N., Lackner A., et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248 4959 (1990) 1109-1112
16. Lu S., Manning S., and Arthos J. Antigen Engineering in DNA Immunization (1999), Humana Press, Totowa, NJ pp. 355-74
17. Jin N.Y., Funahashi S., and Shida H. Constructions of vaccinia virus A-type inclusion body protein, tandemly repeated mutant 7.5 kDa protein, and hemagglutinin gene promoters support high levels of expression. Arch Virol 138 3-4 (1994) 315-330
18. Shida H., Tochikura T., Sato T., Konno T., Hirayoshi K., Seki M., et al. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J 6 11 (1987) 3379-3384
19. Shida H., and Matsumoto S. Analysis of the hemagglutinin glycoprotein from mutants of vaccinia virus that accumulates on the nuclear envelope. Cell 33 2 (1983) 423-434
20. Joklik W.K. The purification of four strains of poxvirus. Virology 18 (1962) 9-18
21. Scheiflinger F., Dorner F., and Falkner F.G. Construction of chimeric vaccinia viruses by molecular cloning and packaging. Proc Natl Acad Sci USA 89 21 (1992) 9977-9981
22. Ishii K., Hasegawa H., Nagata N., Mizutani T., Morikawa S., Suzuki T., et al. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. Virology 351 2 (2006) 368-380
23. Wolffe E.J., Isaacs S.N., and Moss B. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol 67 8 (1993) 4732-4741
24. Hanke T., Blanchard T.J., Schneider J., Hannan C.M., Becker M., Gilbert S.C., et al. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine 16 5 (1998) 439-445
25. Gómez C.E., Nájera J.L., Jiménez E.P., Jiménez V., Wagner R., Graf M., et al. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B. Vaccine 25 15 (2007) 2863-2885
26. Someya K., Ami Y., Nakasone T., Izumi Y., Matsuo K., Horibata S., et al. Induction of positive cellular and humoral responses by a prime-boost vaccine encoded with simian immunodeficiency virus gag/pol. J Immunol 176 3 (2006) 1784-1795
27. Hirsch V.M., Fuerst T.R., Sutter G., Carroll M.W., Yang L.C., Goldstein S., et al. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol 70 6 (1996) 3741-3752
28. Juillard V., Villefroy P., Godfrin D., Pavirani A., Venet A., and Guillet J.G. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur J Immunol 25 12 (1995) 3467-3473
29. Herremans T.M., Reimerink J.H., Buisman A.M., Kimman T.G., and Koopmans M.P. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J Immunol 162 8 (1999) 5011-5018
30. Peng B., Wang L.R., Gómez-Román V.R., Davis-Warren A., Montefiori D.C., Kalyanaraman V.S., et al. Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies. J Virol 79 16 (2005) 10200-10209
31. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., et al. Poxviruses and immune evasion. Annu Rev Immunol 21 (2003) 377-423